Proteomics

Dataset Information

0

Halofuginone, a tRNA-synthetase inhibitor, decreases bulk protein synthesis independently of the integrated stress response


ABSTRACT: The integrated stress response (ISR), a vital homeostatic pathway, is an emerging therapeutic target for a broad range of clinical indications. Halofuginone (HF) is a phase 2 clinical compound that induces the ISR by inhibiting the glutamyl-prolyl-tRNA synthetase (EPRS). Here we report that although HF induces the predicted canonical ISR adaptations consisting of attenuation of protein synthesis and gene expression reprogramming, the former surprisingly occurs independently of GCN2 and eIF2 phosphorylation. Proline supplementation rescues the observed HF-induced changes indicating that they result from an on-target effect due to inhibition of EPRS. We find that attenuation of translation initiation through GCN2-to-eIF2 signaling is not robust enough to prevent translation elongation defects caused by HF. Exploiting this vulnerability, we show that cancer cells presenting an increased proline dependency are sensitized to HF. This work provides novel insights on ISR signaling and a molecular framework to guide the targeted development of HF.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Cell Culture

SUBMITTER: Sew Peak-Chew  

LAB HEAD: Anne Bertolotti

PROVIDER: PXD028744 | Pride | 2022-04-27

REPOSITORIES: Pride

altmetric image

Publications

Cellular responses to halofuginone reveal a vulnerability of the GCN2 branch of the integrated stress response.

Pitera Aleksandra P AP   Szaruga Maria M   Peak-Chew Sew-Yeu SY   Wingett Steven W SW   Bertolotti Anne A  

The EMBO journal 20220425 11


Halofuginone (HF) is a phase 2 clinical compound that inhibits the glutamyl-prolyl-tRNA synthetase (EPRS) thereby inducing the integrated stress response (ISR). Here, we report that halofuginone indeed triggers the predicted canonical ISR adaptations, consisting of attenuation of protein synthesis and gene expression reprogramming. However, the former is surprisingly atypical and occurs to a similar magnitude in wild-type cells, cells lacking GCN2 and those incapable of phosphorylating eIF2α. Pr  ...[more]

Similar Datasets

2024-03-06 | GSE239867 | GEO
2022-07-01 | GSE179559 | GEO
2020-07-24 | PXD011879 | Pride
2024-02-01 | PXD049090 | Pride
2020-02-11 | GSE145004 | GEO
2021-11-11 | GSE174764 | GEO
2009-11-23 | E-GEOD-11496 | biostudies-arrayexpress
2020-02-11 | GSE145003 | GEO
2020-02-11 | GSE145000 | GEO
2020-02-11 | GSE144999 | GEO